SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-347080
Filing Date
2015-10-19
Accepted
2015-10-19 16:46:12
Documents
5
Period of Report
2015-10-14
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d78795d8k.htm 8-K 21041
2 EX-3.1 d78795dex31.htm EX-3.1 22353
3 EX-3.2 d78795dex32.htm EX-3.2 130526
4 EX-99.1 d78795dex991.htm EX-99.1 4520
5 GRAPHIC g78795g81t66.jpg GRAPHIC 14363
  Complete submission text file 0001193125-15-347080.txt   199594
Mailing Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD. SUITE 100 SOUTH SAN FRANCISCO CA 94080 650.515.3185
CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37587 | Film No.: 151164693
SIC: 2834 Pharmaceutical Preparations